K Sudheer¹, M B C R Naidu^2*, Pradeep Kumar Vegi³

¹Associate Professor, Department of General Medicine, GEMS, Srikakulam Andhra Pradesh, INDIA.

^2,3Assistant Professor, Department of Biochemistry, GEMS, Srikakulam, Andhra Pradesh, INDIA.

Email: rd@gems.edu.in

REFERENCES

1. Irshad M, Chaudhari PS. Oxidant and antioxidant system: roleand significance in human body. Indian J Exp Biol. 2002; 40:1233–9.
2. Sies H: Oxidative stress: Oxidants and antioxidants. New York, Academic press; 1991.
3. Halliwell B, Whiteman M.Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do itand what do the results mean? [Review]. Br J Pharmacol2004;142:231-55.
4. HalliwellB.Role of free radicals in the neurodegenerative diseases:therapeutic implications for antioxidant treatment[Review]. Drugs Aging2001;18: 685-716.
5. Isabella Dalle-Donne, Rossi Ranieri, Colombo Roberto, GiustariniDaniela, MilzaniAldo. Biomarkers of Oxidative Damage inHuman Disease. Clinical Chemistry2006; 52(4):601-623.
6. Maritim AC, Sanders RA and WatkinsJB.Diabetes, oxidative stress and antioxidants: a review. J BiochemMol Toxicol2003;17:24-38.

7. Stephens Jeffrey W, Gable David R, Hurel Steven J, Miller George J, Cooper Jackie A, Humphries Steve E.Increased Plasma Markersof Oxidative Stress Are Associated with Coronary HeartDisease in Males with Diabetes Mellitus and with 10-YearRisk in a Prospective Sample of Males. Clinical Chemistry2006;52(3):446-452.
8. Ruderman NB, Williamson JR, Brownlee M.Glucose and diabeticvascular disease. FASEB J1992;6(11):2905-14.
9.  American Diabetic Association.Guidelines. Standards of medicalcare in Diabetes. Diabetes Care2005;28(Supplement 1):S4-36.
10.  Guillermo Zalba, Fortuño Ana, DíezJavier.Oxidative stress andatherosclerosis in early chronic kidney disease. Nephrol DialTransplant2006;21:2686-2690.
11.  Wolff SP.Diabetes mellitus and free radicals. Free radicals,transition metals and oxidative stress in the etiology of diabetesmellitus and complications. Br Med Bull1993;49:642-652.
12.  Brownlee M.Biochemistry and molecular cell biology of diabeticcomplications. Nature 2001, 414:813-820.
13. Wieruszwysocka B, Wysocki H, Byks H, Zozulinska D, WykretowiczA, KazierczakM.Metabolic control quality and free radicalactivity in diabetic patients, Diabetes Res. Clin Pract1995;27:193-197.
14. Heistad Donald D.Oxidative Stress and VascularDisease. ArteriosclerThrombVasc Biol200;26:689-95.
15.  Liu Shang Xi, Hou Fan Fan, GuoZhiJian, Nagai Ryoji, Zhang Wei Ru, Liu ZhiQiang, et al,.Advanced Oxidation Protein Products AccelerateAtherosclerosis Through Promoting Oxidative Stress andInflammation. ArteriosclerThrombVasc Biol2006; 26:1156-1162.
16. Azen SP, Qian D, Mack WJ, Sevanian A, Selzer RH, Liu CRetal,.Effect of supplementary antioxidant vitaminintake on carotid arterial wall intima-media thickness in acontrolled clinical trial of cholesterol lowering. Circulation1996;94:2369-2372.
17.  Heart Protection Study Collaborative Group.MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in20,536 high-risk individuals: a randomised placebo-controlledtrial. Lancet 2002;360:23-33.
18. Engler MM, Engler MB, Malloy MJ, Chiu EY, Schloetter MC, Paul SMetal,. Antioxidant vitamins Cand E improve endothelial function in children with hyperlipidemia:Endothelial Assessment of Risk from Lipids inYouth (EARLY) Trial. Circulation2003;108:1059-1063.
19. Ashour M, Salem S, Hassaneen H, EL-Gadban H, Elwan N, AwadAetal,.Antioxidant status and insulin dependent diabetesmellitus (IDDM). J Clin BiochemNutr1999;26:99-107.
20. MarraGiampiero, CotroneoPatrizia, Pitocco Dario, Manto Andrea, diLeo Mauro AS, Ruotolo Valeria et al,.Early Increase of OxidativeStress and Reduced Antioxidant Defenses in Patients withUncomplicated Type 1 Diabetes. Diabetes Care2002;25:370-375.
21.  Rice-Evans C, Miller NJ.Total antioxidant status in plasma andbody fluids. Methods Enzymol234;279-293.
22. Doumas BT, Watson WA, Biggs HG.Albumin standards and themeasurement of serum albumin with bromocresolgreen.ClinChem Acta1971;31:87.
23. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AGetal,.Determination of carbonyl contentinoxidatively modified proteins. In Methods in Enzymology Volume186. Edited by: Pecker L, Glazer AN. New York, Academic; 1990:464-478.
24. Raghuramulu N, Madhavan Nair K, Kalyanasundaram S.A manual oflaboratory techniques. National Institute of Nutrition, Hyderabad. India; 2003.
25. BeutlerE.Red cell metabolism. In A manual of biochemical methods 3rd edition. New York; 1984.
26. Flohe L, GunzlerWA.Assays of glutathione peroxidase, Methodsenzymol. 1984;105:114-121.
27. Renu AK, Timothy SK, Engerman RL: Abnormalities of retinolmetabolism in diabetes or experimental galactosemia. FreeradicalBiol Med 1997;22(4):587-92.
28. Bar-Or D, Curtis G, Rao N, Bampos N, Lau E.Characterization of the Co2+ and Ni2+binding amino acid residues of the Nterminus of human albumin, An insight into the mechanism of a new assay for myocardial ischemia, Eur J Biochem 2001; 268: 42-47.
29. Ukinc K, Eminagaoglu S, Ersoz HO, Erem C, Karahan C, Hacihasanoglu AB, et al. A novel indicator of widespread endothelial damage and ischemia in diabetic patients: ischemia-modified albumin, Endocrine 2009; 36: 525-535.
30. Piwowar A, Knapik-Kordecka M, WarwasM.Connection between Ischemia-Modified Albumin levles and markers of diabetic nephropathy and oxidative protein damage in type 2 diabetic patients, AdvClinExp Med 2009; 18: 353-360.
31. Piwowar A, Knapik-Kordecka M, WarwasM.Comparison of usefulness of plasma levels of oxidatively modified forms of albumin in estimating kidney dysfunction in diabetic patients, Clin Invest Med 2010; 33: E109-E116.
32. Cichota LC, Moresco RN, Duarte MM, Da Silva JE. Evaluation of ischemia-modified albumin in anemia associated to chronic kidney disease, J Clin Lab Anal 2008; 22: 1-5.
33. Krzystek-Korpacka M, Neubauer K, Berdwoska I, Boehm D, Zielinski B, Petryszyn P, et al. Boehm enhanced formation of advanced oxidation protein products in IBD. Inflamm Bowel Dis 2008; 14: 794-802.
34. Dahiya K, Aggarwal K, Seth S, Singh V, Sharma TK. Type 2 Diabetes mellitus without vascular complications and Ischemia modified albumin. Clin Lab 2010; 56: 187-190.